Tomoki Sakakida, Toshiki Masuishi, Takuma Onoe, Keigo Komine, Kan Yonemori, Takao Fujisawa, Kentaro Tokumo, Kazuaki Harada, Satoshi Hamauchi, Taito Esaki, Yukihiko Hiroshima, Satomi Watanabe, Hiroyuki Takeda, Masako Asayama, Waki Hosoda, Hiroya Taniguchi, Hidetoshi Hayashi, Kei Muro. "Phase II basket trial of brigatinib for ALK fusion–positive solid tumors: ALLBREAK trial (WJOG15221M).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3105